


Ask a doctor about a prescription for OMEPRAZOL NORMON 40 mg POWDER FOR SOLUTION FOR INFUSION
Package Leaflet: Information for the Patient
Omeprazole Normon 40 mg Powder for Solution for Infusion EFG
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the Package Leaflet:
Omeprazole Normon contains the active substance omeprazole. It belongs to a group of medicines called “proton pump inhibitors” that work by reducing the amount of acid produced by the stomach.
Omeprazole powder for solution for infusion can be used as an alternative to oral treatment.
Do not use Omeprazole Normon
Omeprazole Normon should not be administered to you if you are affected by any of the above conditions. If in doubt, talk to your doctor, pharmacist, or nurse before being given this medicine.
Talk to your doctor, pharmacist, or nurse before receiving Omeprazole Normon.
Severe skin reactions, such as Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP) have been reported with Omeprazole Normon. You should stop taking Omeprazole Normon and seek immediate medical attention if you experience any of the symptoms related to these severe skin reactions described in section 4.
Omeprazole Normon may mask the symptoms of other diseases. Therefore, if you experience any of the following conditions before starting to use Omeprazole Normon or after being administered, talk to your doctor immediately:
If you are taking proton pump inhibitors like Omeprazole Normon, especially for more than one year, you may have a slightly increased risk of hip, wrist, and spine fractures. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).
If you experience a skin rash, especially in areas of the skin exposed to the sun, talk to your doctor as soon as possible, as it may be necessary to interrupt treatment with Omeprazole Normon. Remember to mention any other symptoms you may notice, such as joint pain.
When taking omeprazole, kidney inflammation can occur. The signs and symptoms can include decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. You should inform your doctor of these signs.
Do not administer this medicine to children under 18 years of age. Experience with the use of intravenous formulations of Omeprazole Normon in pediatric patients is limited.
Tell your doctor, pharmacist, or nurse if you are taking or have recently taken or might take any other medicines, including those obtained without a prescription. This is because Omeprazole Normon may affect the action of some medicines and some medicines may affect the action of Omeprazole Normon.
Do not take Omeprazole Normon if you are taking a medicine that contains nelfinavir(used to treat HIV infection).
Tell your doctor, pharmacist, or nurse if you are taking any of these medicines:
If your doctor has prescribed the antibiotics amoxicillin and clarithromycin in addition to Omeprazole Normon to treat ulcers caused by Helicobacter pyloriinfection, it is very important that you inform them of any other medicines you are taking.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor, pharmacist, or nurse before being given this medicine.
Omeprazole is excreted in breast milk, but it is unlikely to affect the baby when used at therapeutic doses. Your doctor will decide whether you can receive Omeprazole Normon if you are breastfeeding.
Driving and Using Machines
Omeprazole Normon is unlikely to affect your ability to drive or use tools or machines. Side effects such as dizziness and visual disturbances (see section 4) may occur. If they do, you should not drive or use machines.
Important Information about Some of the Ingredients of Omeprazole Normon
This medicine contains less than 23 mg (1 mmol) of sodium per 40 mg vial of omeprazole, so it is essentially “sodium-free”.
.
If You Have Been Given More Omeprazole Normon Than You Should
If you think you have been given more omeprazole than you should, tell your doctor immediately.
If you have any further questions about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If You Notice Any of the Following Serious Side Effects, Stop Using Omeprazole and Consult Your Doctor Immediately(May Affect Up to 1 in 1000 People) or Very Rare (May Affect Up to 1 in 10,000 People) but Serious:
Other side effects are:
Common Side Effects(May Affect Up to 1 in 10 People)
Uncommon Side Effects(May Affect Up to 1 in 100 People)
Rare Side Effects(May Affect Up to 1 in 1000 People)
Very Rare Side Effects(May Affect Up to 1 in 10,000 People)
Frequency Not Known(Cannot Be Estimated from Available Data)
In very rare cases, omeprazole can affect the white blood cells in the blood and cause immunodeficiency. If you have an infection with symptoms such as fever with a severely deteriorated general condition or fever with symptoms of local infection, such as sore throat, or difficulty urinating, you should consult your doctor as soon as possible to perform a blood test and rule out a lack of white blood cells (agranulocytosis). It is important that you provide information about the medicine you are taking at that time.
Reporting Side Effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
The reconstituted infusion solution with 9 mg/ml of sodium chloride (0.9%) should be used within 12 hours of preparation.
The reconstituted infusion solution with 50 mg/ml of glucose (5%) should be used within 6 hours of preparation.
From a microbiological point of view, this medicine should be used immediately, unless it has been reconstituted in controlled and validated aseptic conditions.
Appearance and Packaging
It is presented in 1 vial.
The white powder in the vial must be incorporated into a solution before administration.
Package sizes: 1 and 50 vials.
Marketing Authorization Holder and Manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos, Madrid
SPAIN
This leaflet was last revised in:February 2025
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/
You can access detailed and updated information on this medicine by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address:
https://cima.aemps.es/cima/dochtml/p/67270/P_67270.html
---------------------------------------------------------------------------------------------------------------------------
This information is intended only for healthcare professionals:
The entire contents of each vial should be dissolved in approximately 5 ml and diluted immediately thereafter to 100 ml. A 9 mg/ml sodium chloride (0.9%) infusion solution or a 50 mg/ml glucose (5%) infusion solution should be used. The pH of the infusion solution affects the stability of omeprazole, which should not be diluted in other solvents or in other quantities.
Preparation
Alternative method of preparation of infusions in flexible containers
Do not use if particles are observed in the reconstituted solution.
The infusion solution will be administered as an intravenous infusion over 20-30 minutes.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for OMEPRAZOL NORMON 40 mg POWDER FOR SOLUTION FOR INFUSION – subject to medical assessment and local rules.